Neuronal and microglial cathepsins in aging and age-related diseases.
It has been long believed that cathepsins compensate for each other because of their overlapping substrate specificities. However, there is increasing evidence that disturbance of the normal balance of their enzymatic activities is the first insult in brain aging and age-related diseases. The imbalance of cathepsins may further cause age-related neuropathological changes such as accumulation of autophagic vacuoles and the formation of ceroid-lipofuscin leading to neuronal dysfunction and damage. Leakage of cathepsins due to the fragility of lysosomal membranes during aging also contributes to neurodegeneration. Furthermore, the deficiency of cathepsin D has been recently revealed to provoke a novel type of lysosomal storage disease associated with massive neurodegeneration. In these animals, microglia are activated to initiate inflammatory and cytotoxic responses by binding and phagocytosis of storage neurons. Activated microglia also release some members of cathepsins to induce neuronal death by degrading extracellular matrix proteins. Thus the microglial activation possibly through sensing neuronal storage may also be an important causative factor for neurodegeneration in lysosomal storage diseases and age-related diseases such as Alzheimer's disease. This review describes the pathological roles of neuronal and microglial cathepsins in brain aging and age-related diseases.
Nakanishi
Hiroshi
H
Laboratory of Oral Aging Science, Faculty of Dental Sciences, Kyushu University, Fukuoka 812-8582, Japan. nakan@dent.kyushu-u.ac.jp
D000375:Aging / Q000502:physiology*; D000818:Animals; D001921:Brain / Q000201:enzymology / Q000502:physiology; D001923:Brain Chemistry / Q000502:physiology; D002403:Cathepsins / Q000502:physiology*; D005853:Geriatrics; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000378:metabolism; D017628:Microglia / Q000502:physiology*; D009474:Neurons / Q000502:physiology*
D002403:Cathepsins